Risk Stratification in Acute Heart Failure: Rationale and Design of the STRATIFY and DECIDE Studies

American Heart Journal - United States
doi 10.1016/j.ahj.2012.07.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Risk Stratification in Acute Heart Failure: Reply

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) Trial: Design and Rationale

American Heart Journal
Cardiovascular MedicineCardiology
2017English

Rationale and Design of the Multicentre, Randomized, Double-Blind, Placebo-Controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2011English

Molecular Biomarkers for Diagnostics, Risk Stratification and Prediction of Chronic Heart Failure

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Rationale and Design of the ADVOR (Acetazolamide in Decompensated Heart Failure With Volume Overload) Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Coronary Risk Stratification of Patients With Newly Diagnosed Heart Failure

Open Heart
Cardiovascular MedicineCardiology
2019English

Is There a Rationale for Antiplatelet Therapy in Acute Heart Failure?

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2013English

Risk Stratification for Death and All-Cause Hospitalization in Heart Failure Clinic Outpatients

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Prognosis and Risk Stratification in Patients With Decompensated Heart Failure Receiving Inotropic Therapy

Open Heart
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy